Mark is a Partner in Osborne Clarke's corporate team and Financial Services sector teams.

Mark is a highly experienced corporate lawyer, regularly advising on a broad range of matters including business strategy, M&A, takeovers, IPOs, fundraising, joint ventures, restructuring and corporate governance. The matters Mark advises on are frequently strategically important and/or complex, often cross-border.

Mark's clients range from large institutions and listed businesses through to funds/investors, scale-ups and successful entrepreneurs.

Mark has broad experience across a number of industry sectors but has particular experience and focus in the Financial Services and FinTech sectors, as well as TMT / Tech, Media and Comms.

Mark has been at Osborne Clarke since 2008. Prior to that he worked at Slaughter and May in London, with a period working in New York.

London & Country Mortgages

Sale of a 25% stake in the UK's leading independent mortgage broker, London & Country Mortgages (L&C), to Experian plc.

Hargreaves Lansdown plc

Rectification of unlawful dividends paid by FTSE100 UK leading investment platform Hargreaves Lansdown plc.

FeverTree Drinks plc

£158m AIM IPO of FeverTree Drinks plc.


Acquisition by Computershare of international share schemes business Equatex from private equity firm Montagu.

Tribal Group plc

£60m rescue rights issue and disposal of Synergy business for software business Tribal Group plc.


£50m acquisition by PTC of software business Atego Systems Limited

The UNITE Group plc

£85m retail bond issue for The UNITE Group plc.


Advised on FTSE-250 listed company UNITE's debut retail bond issue.


Advised on their debut retail bond issue

Seven Technologies

Advised on its £7m takeover of AIM listed Datong, leading provider of intelligence equipment and solutions, creating one of the sectors largest independent specialist technology engineering businesses

Clydesdale Bank

Advised Clydesdale Bank Corporate & Structured Finance on its funding of a merger between two leading speciality pharmaceutical companies. The bank has agreed a £16m senior funding package to support IS Pharma plc and Sinclair Pharma plc, which are planning to join forces to create Sinclair IS Pharma plc, a substantial, fully integrated pan-European speciality pharmaceutical business

The Wealth Preservation Fund Plc

Advised on its formation and the arrangements between it and its co-sponsors.


Advised on its $50m acquisition of Atego, a developer of model-based systems and software engineering applications

Actual Experience plc

Advised Actual Experience plc on £16m share placing from new and existing shareholders

Empresaria Group

Advised Empresaria, an international specialist staffing group, on the £3.3m accelerated bookbuild used to part finance the acquisition of US healthcare recruiter PS.